
Pelotonia Institute for Immuno-Oncology
@ohiostatepiio
Pelotonia Institute for Immuno-Oncology. A bench-to-bedside research initiative accelerating therapeutics that use the immune system to fight cancer. #PIIO
ID: 1450460864335724545
http://cancer.osu.edu/PIIO 19-10-2021 13:57:01
958 Tweet
1,1K Followers
415 Following




Looking forward to participating in this event, on “Advances in Cancer Immunotherapy: Translating Discoveries into Clinical Applications” ASCO Chinese American Hematologist & Oncologist Network Dr. Patrick Hwu asco.org/annual-meeting…

📝New publication from Elshad Hasanov, MD, PhD & colleagues: STARLITE 1: Phase 1b/2 Study of Combined 177Lu-Girentuximab plus Cabozantinib and Nivolumab in Treatment-naïve Patients with Advanced Clear-cell Renal Cell Carcinoma doi.org/10.1016/j.euf.…


Christian Rolfo will be the keynote speaker for the Spring 2025 SWOG Lung Cancer Committee Meeting in San Francisco with a talk titled “Liquid Biopsy in the Assessment of Minimal Residual Disease.” #swog


We're looking forward to this event on “Advances in #CancerImmunotherapy” at #ASCO2025! Leading experts, Drs. Dr. Patrick Hwu, Jedd Wolchok, Lei Zheng, Zihai Li, MD, PhD, will discuss breakthroughs in translating discoveries into clinical applications. Don’t miss it! 📅 May 30, 2025 📍 Hyatt


Welcome, Dr. Ahn! Looking forward to impactful discoveries in the The James, Pelotonia Institute for Immuno-Oncology Center for #InnateImmunity and #Inflammation! Glen Barber Lab

Check out this review in J Hematol Oncol. highlighting recent advances in #therapeutic_strategies for #NSCLC, featuring contributions from Po-Lan Su, Naoki Furuya, Asrar AlAhmadi, MD, MAS-CR - أسرار الأحمدي, Christian Rolfo, Zihai Li, MD, PhD, David Carbone MD, & Kai He. pubmed.ncbi.nlm.nih.gov/40140911/ Ohio State Medical Oncology


New research by the lab of Ohio State Medical Oncology Pelotonia Institute for Immuno-Oncology researcher Dr. Feng Hong reveals how #CNPY2 drives DSS-induced #colitis through the #macrophage_ROS axis. This work sheds light on key mechanisms in #inflammation and colitis. Full study: pubmed.ncbi.nlm.nih.gov/40262233/



Dr. Hakimeh Ebrahimi from Pelotonia Institute for Immuno-Oncology Ohio State talking about modulating the TME and its impact on T cells at the 6th Annual IO symposium Schulich WesternU London Health Sciences Centre Research Institute


Congrats 🎉to Dr. Hakimeh Ebrahimi-Nik, for her presentation on modulating the #TME and its impact on #Tcells! Ohio State Medical Oncology The James, Pelotonia Institute for Immuno-Oncology

New research in Nature Communications on rapid assay development for low input targeted #proteomics using a versatile linear ion trap. This method promises to accelerate #immuno_oncology research with #targeted_proteomics using minimal sample input. Ariana Shannon Brian Searle Zihai Li, MD, PhD


April was a big month in the effort to create a cancer-free world Ohio State. Click to learn about new awards, announcements and more from The James team. cancer.osu.edu/news/april-202…

In a recent publication, researchers from Pelotonia Institute for Immuno-Oncology & Nationwide Children's Hospital discuss how #metabolic interactions shape #immune responses in #tumors, underscoring the potential of targeting #metabolic_pathways to enhance #immunotherapy outcomes. pmc.ncbi.nlm.nih.gov/articles/PMC11… Gang Xin


It's an exciting time to be a Buckeye. The new The Ohio State University Wexner Medical Center Inpatient Tower will change health care in Ohio, expanding access and innovation in 2026.
